Bioengineering Organs for Transplants
Miromatrix (miromatrix.com) scores 72 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 30th percentile of 16240 Healthcare brands.
Miromatrix is a biomedical engineering company headquartered in Eden Prairie, United States, founded in 2009. The company develops a proprietary perfusion decellularization and recellularization technology aimed at creating fully functional, transplantable human organs. Its stated mission is to eliminate the organ transplant waitlist by bioengineering organs for patients who may not receive a traditional donor organ. Miromatrix operates within the healthcare and technology categories, targeting transplant patients, medical professionals, researchers, and healthcare investors focused on regenerative medicine.
| Brand Name | Miromatrix |
|---|---|
| Domain | miromatrix.com |
| Industry | Healthcare, Technology |
| Founded | 2009 |
| Headquarters | Eden Prairie |
| Main Competitors | United Therapeutics (77/100), eGenesis, Organovo (78/100), Humacyte (80/100), LyGenesis (68/100) |
Moz Domain Authority 34/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Discover Miromatrix, pioneering a novel technology to create fully transplantable human organs in hopes of providing new options for transplantation" (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Product/Article schema, og:title, og:description, og:image, og:type, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram; no detected presence on LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Miromatrix?", Claude could identify the brand as of October 2026. Miromatrix Medical is a biotech company developing bioengineered human organs, such as livers and kidneys, using its proprietary decellularization and recellularization technology to strip donor organs of cells and repopulate them with human cells. The company is working toward p Best known for Bioengineering transplantable human organs using decellularized scaffolds from animal organs recellularized with human cells.
When asked "Best brands similar to Miromatrix?", Claude would recommend Miromatrix as of October 2026. It's one of the few companies pursuing whole-organ bioengineering for transplant alternatives, so it would come up in discussions of regenerative medicine or organ bioengineering innovators.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Miromatrix's main competitors in Healthcare: United Therapeutics (77/100), Organovo (78/100), Humacyte (80/100), LyGenesis (68/100).
Sources: Brand Analyzer scan
Miromatrix has limited AI-search visibility, scoring 31/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 32, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Miromatrix official site
Miromatrix was founded in 2009. Miromatrix operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Miromatrix is headquartered in Eden Prairie. Miromatrix operates in the Healthcare category.
Sources: Wikidata
Miromatrix scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Miromatrix official site
Miromatrix's core offering is its proprietary perfusion decellularization and recellularization technology platform, which is used to bioengineer fully functional, transplantable human organs for patients awaiting transplants.
Sources: Miromatrix official site
Miromatrix is a biomedical engineering company based in Eden Prairie, United States, founded in 2009. It develops technology aimed at creating fully transplantable human organs through bioengineering, positioning itself as a pioneer in regenerative medicine focused on solving the organ shortage crisis.
Sources: Miromatrix official site
Miromatrix uses a proprietary perfusion decellularization and recellularization technology to bioengineer fully functional, transplantable human organs. The process involves removing cells from donor organ scaffolds and then repopulating them with new cells to create organs intended for transplantation into patients.
Sources: Miromatrix official site
Miromatrix can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Miromatrix official site
Miromatrix is known for pioneering perfusion decellularization and recellularization technology used to bioengineer transplantable human organs, with the stated goal of eliminating the organ transplant waitlist.
Sources: Miromatrix official site
According to the known facts, Miromatrix's work is intended for patients awaiting organ transplants, and it engages with the medical and transplant community, researchers, and healthcare investors interested in regenerative medicine solutions.
Sources: Miromatrix official site
Miromatrix scores 31/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Miromatrix has a weak AI-visibility profile at 31/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 34/100 and thin schema.org structured data. In a live check, Claude could already identify Miromatrix from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Miromatrix: Mirbeau Inn & Spa (72/100), Miracle-Ear (72/100), Mission Pet Health (72/100), Mitra Keluarga (72/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.